![]() |
市場調查報告書
商品編碼
2037410
全球物理治療沐浴及身體護理市場預測至2034年-按產品類型、療效、活性成分、分銷管道、價格範圍、應用、認證、最終用戶和地區分類的分析Therapeutic Bath & Body Market Forecasts to 2034 - Global Analysis By Product Type, Therapeutic Benefit, Active Ingredient, Distribution Channel, Price Tier, Application, Certification, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球治療性沐浴和身體護理市場將達到 128 億美元,並在預測期內以 7.9% 的複合年成長率成長,到 2034 年達到 236 億美元。
療癒沐浴及身體護理產品包括浴鹽、礦物浸浴鹽、泡澡球、發泡錠、療癒身體油、藥皂、潤膚膏、修復膏和足部護理產品。這些產品含有活性成分,旨在放鬆和恢復肌肉、緩解壓力和焦慮、改善睡眠、改善皮膚狀況以及排毒。它們透過局部和沐浴時的吸收等機制發揮作用,彌合了傳統個人護理和市售療癒保健產品之間的差距。
投資自我護理和健康療法產品
在人們對醫療成本控制日益關注、預防性自我護理觀念不斷增強以及對便捷的壓力管理和恢復方案需求不斷成長的推動下,消費者對居家療癒體驗的投入正在不斷擴大。這使得療癒型沐浴及身體護理產品類型,透過基於實證醫學的臨床成分,提供具有相應療效的產品,從而支撐其高價位。研究表明,使用鎂、CBD和植物來源成分的療癒型沐浴產品在運動後恢復、睡眠品質和壓力指標方面均取得了顯著成效,激發了各類消費者嘗試這些產品的興趣。
關於治療效果的監管論證要求
個人保健產品作為化妝品和非處方成藥在療效方面的監管界限,限制了聲稱具有特定症狀療效的沐浴和身體護理產品的行銷傳播。因此,為了在無需註冊臨床試驗或獲得FDA核准的情況下,透過允許的化妝品功效聲明適當地傳達療效,品牌需要投入大量資金以確保合規。
運動復健治療體位的高品質
針對運動後恢復的物理治療沐浴產品,例如鎂浴鹽、CBD外用產品和冷療浴液,其市場定位瞄準了運動營養和恢復領域龐大且快速成長的消費群體。這創造了一個高階市場機遇,並得到了運動員代言和運動醫學相關臨床交流的支持,也反映出該領域消費者比一般健康消費者更願意投資於物理治療產品。
與藥品和非處方藥(OTC)替代品的競爭。
一些已獲美國食品藥物管理局 (FDA) 批准的非成藥產品類型,例如用於緩解肌肉疼痛的外用鎮痛藥、治療濕疹的皮膚科藥物以及藥用足部護理產品,都擁有經 FDA核准的臨床療效聲明。相較之下,由於法律規範的限制,沐浴及身體護理類產品無法做出類似的療效聲明。因此,消費者在比較藥品和以健康為導向的沐浴及身體護理類產品的療效時,二者在可靠性方面有明顯的競爭差距。
新冠疫情加劇了消費者的壓力和睡眠障礙,促使人們加大對居家健康習慣的投入,並顯著提升了物理治療沐浴及身體護理產品類型的試用和普及率。疫情結束後,人們對自我護理文化的持續投入以及居家健康習慣的養成,將持續支撐物理治療沐浴及身體護理市場的穩定發展。
在預測期內,身體潤膚膏和藥膏細分市場預計將佔據最大的市場佔有率。
預計在預測期內,潤膚膏和藥膏將佔據最大的市場佔有率。這主要歸功於具有廣泛應用前景的潤膚膏和藥膏產品,包括緩解肌肉疼痛、修復乾燥皮膚屏障功能、促進創傷治療以及提供芳香療法帶來的放鬆體驗。這些產品採用廣泛用途的「免沖洗」配方,可在日常活動中持續釋放有效成分,從而在沐浴和身體護理產品系列中創造最穩定、最頻繁的重複購買行為。
在預測期內,肌肉放鬆和恢復細分市場預計將呈現最高的複合年成長率。
在預測期內,肌肉放鬆和恢復領域預計將呈現最高的成長率。這主要歸功於消費者群體的快速成長,他們重視健身和運動表現,並投資於以實證為基礎的訓練後恢復方案,這些方案除了使用成熟的運動營養補充劑外,還包括物理治療浴和外用產品,作為便捷且經濟高效的恢復選擇。休閒運動員數量的增加以及職場體力勞動後對恢復日益成長的需求,正在推動肌肉放鬆市場需求的成長。
在預測期內,北美預計將佔據最大的市場佔有率。這主要歸功於美國擁有全球最發達的個人護理治療市場,旗下擁有 Dr. Teal's、Village Naturals Therapy、Lush 和 Bath & Body Works 等領先品牌,這些品牌在國內銷售額可觀;此外,美國還擁有強大的大眾市場分銷網路,透過 Target、沃爾瑪和藥店等管道銷售治療性沐浴產品以及根深蒂固的注重健康的消費文化。
在預測期內,亞太地區預計將呈現最高的複合年成長率。這主要歸因於以下幾個因素:日本和韓國的療癒沐浴文化為現代療癒沐浴產品的創新提供了天然的接受基礎;中國和澳洲高階健康消費市場的快速成長;以及本土療癒沐浴和身體保養品牌的擴張,這些品牌正在建立一個與亞洲傳統沐浴健康文化相契合的、具有競爭力的區域生態系統。
According to Stratistics MRC, the Global Therapeutic Bath & Body Market is accounted for $12.8 billion in 2026 and is expected to reach $23.6 billion by 2034 growing at a CAGR of 7.9% during the forecast period. Therapeutic bath and body products refer to bath salts and mineral soaks, bath bombs and fizzers, therapeutic body oils, medicated soaps, body balms and healing salves, and foot care products formulated with active therapeutic ingredients targeting muscle relief and recovery, stress and anxiety relief, sleep enhancement, skin condition management, and detoxification benefits through topical application and bath immersion delivery mechanisms that bridge the boundary between conventional personal care and over-the-counter therapeutic wellness product categories.
Self-Care Wellness Therapeutic Product Investment
Consumer investment in at-home therapeutic wellness experiences driven by healthcare cost management motivation, preventive self-care philosophy adoption, and demand for accessible stress management and recovery solutions is driving therapeutic bath and body product category expansion beyond conventional personal care positioning toward therapeutic benefit delivery that justifies premium pricing from evidence-adjacent clinical ingredient communication. Documented sports recovery, sleep quality, and stress marker outcomes from magnesium, CBD, and botanical therapeutic bath formulation research are generating consumer trial motivation across diverse demographic segments.
Therapeutic Claim Regulatory Substantiation Requirements
Regulatory boundaries between cosmetic personal care products and OTC drug therapeutic claims constraining marketing communication for bath and body products making specific condition treatment benefit statements, requiring significant regulatory navigation investment for brands seeking to communicate therapeutic product efficacy through permissible cosmetic claim language that adequately conveys benefit without triggering drug classification that mandates clinical trial registration and FDA approval pathway commitment.
Sports Recovery Therapeutic Positioning Premium
Sports performance recovery market positioning for therapeutic bath and body products including magnesium bath salts, CBD topical products, and cryotherapy bath solutions as athletic recovery aids targeting the large and rapidly growing sports nutrition and recovery consumer demographic creates premium market opportunity with higher consumer willingness to invest in therapeutic positioning than general wellness consumers, supported by athlete endorsement and sports medicine adjacent clinical communication.
Pharmaceutical OTC Therapeutic Alternative Competition
Established OTC pharmaceutical therapeutic product categories including muscle pain topical analgesics, dermatological eczema treatments, and medicated foot care products commanding FDA-approved clinical efficacy claims that therapeutic bath and body product brands cannot match through cosmetic regulatory framework claim limitations, creating competitive credibility gap in consumer therapeutic benefit comparison shopping between pharmaceutical and wellness-positioned therapeutic bath and body alternatives.
COVID-19 elevated consumer stress, sleep disruption, and home wellness ritual investment creating substantial therapeutic bath and body product category trial and adoption. Post-pandemic sustained self-care cultural investment and home wellness routine normalization continue supporting therapeutic bath and body market stability.
The body balms & salves segment is expected to be the largest during the forecast period
The body balms & salves segment is expected to account for the largest market share during the forecast period, due to the broad application scope of therapeutic body balm and healing salve products addressing muscle pain management, dry skin barrier repair, wound healing support, and aromatherapy relaxation through versatile leave-on topical formulation that enables continuous therapeutic ingredient delivery throughout daily activity, generating the most consistent high-frequency repurchase behavior within the therapeutic bath and body product portfolio.
The muscle relief & recovery segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the muscle relief & recovery segment is predicted to witness the highest growth rate, driven by rapidly growing fitness and athletic performance consumer demographic investing in evidence-informed post-workout recovery protocols that incorporate therapeutic bath and topical products as accessible, cost-effective recovery modalities alongside established sports nutrition supplementation. Growing recreational athlete populations and workplace physical labor recovery motivation create expanding muscle relief market demand.
During the forecast period, the North America region is expected to hold the largest market share, due to the United States hosting the world's most developed therapeutic personal care market with leading brands including Dr Teal's, Village Naturals Therapy, Lush, and Bath & Body Works generating substantial domestic revenue, strong mass market therapeutic bath product distribution through Target, Walmart, and pharmacy channels, and high consumer wellness investment culture.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to Japanese and Korean therapeutic bath culture providing natural adoption foundations for modern therapeutic bath product innovation, rapidly growing premium wellness consumer markets in China and Australia, and expanding domestic therapeutic bath and body brand development creating competitive regional product ecosystems aligned with Asian traditional bathing wellness traditions.
Key players in the market
Some of the key players in Therapeutic Bath & Body Market include Johnson & Johnson Services Inc., Unilever PLC, Procter & Gamble Company, L'Oreal S.A., Bath & Body Works Inc., L'Occitane International S.A., The Body Shop International Limited, Kneipp GmbH, Dr Teal's (PDC Brands), Village Naturals Therapy, Lush Retail Ltd., Aveda Corporation, Sanofi S.A., GlaxoSmithKline plc, Beiersdorf AG, and Clarins Group.
In April 2026, Dr Teal's (PDC Brands) launched a new sports recovery magnesium bath salt collection combining ultra-high magnesium chloride concentration with menthol and arnica therapeutic actives targeting the fitness and athletic recovery consumer segment through sporting goods and gym retail channels.
In March 2026, Kneipp GmbH expanded its therapeutic hydrotherapy bath product range with new sleep-enhancement valerian and hops bath salt formulation validated through independent sleep quality clinical study demonstrating significant sleep onset time improvement versus placebo bath control.
In December 2025, Lush Retail Ltd. introduced a muscle relief therapeutic bath bomb collection using pharmaceutical-grade magnesium sulfate, CBD extract, and eucalyptus essential oil complex targeting post-workout recovery positioning across its global specialty retail store network.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.